These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

75 related articles for article (PubMed ID: 795583)

  • 1. The carriage of Escherichia coli on the peri-urethral area and in the feces in patients on long term low dose cotrimoxazole therapy.
    Cattell WR; McSherry MA; Brooks HL; O'Grady FW
    Clin Nephrol; 1976 Dec; 6(6):506-8. PubMed ID: 795583
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Prophylactic efficacy of nitrofurantoin macrocrystals and trimethoprim-sulfamethoxazole in urinary infections. Biologic effects on the vaginal and rectal flora.
    Stamey TA; Condy M; Mihara G
    N Engl J Med; 1977 Apr; 296(14):780-3. PubMed ID: 320482
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Trimethoprim/sulphamethoxazole resistance in Escherichia coli and Klebsiella spp. urinary isolates.
    Obaseiki-Ebor EE
    Afr J Med Med Sci; 1988 Sep; 17(3):175-9. PubMed ID: 2845759
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Genetic evidence supporting the fecal-perineal-urethral hypothesis in cystitis caused by Escherichia coli.
    Yamamoto S; Tsukamoto T; Terai A; Kurazono H; Takeda Y; Yoshida O
    J Urol; 1997 Mar; 157(3):1127-9. PubMed ID: 9072556
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Sensitivity to sulfamethoxazole-trimethoprim of Escherichia coli isolated from claves (author's transl)].
    Wierup M
    Nord Vet Med; 1974 Nov; 26(11):626-33. PubMed ID: 4615298
    [No Abstract]   [Full Text] [Related]  

  • 6. [Antibiotic resistance of Escherichia coli. Importance of the resistance to trimethoprim-sulfamethoxazole].
    Riou B; Richard C; Rimailho A; Coquin Y; Rottman E; Auzepy P
    Ann Med Interne (Paris); 1985; 136(5):412-5. PubMed ID: 3904566
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Carriage of antimicrobial resistant Escherichia coli in adult intestinal flora.
    Newman MJ; Seidu A
    West Afr J Med; 2002; 21(1):48-50. PubMed ID: 12081343
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Prevalence and predictors of trimethoprim-sulfamethoxazole resistance among uropathogenic Escherichia coli isolates in Michigan.
    Brown PD; Freeman A; Foxman B
    Clin Infect Dis; 2002 Apr; 34(8):1061-6. PubMed ID: 11914994
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Trimethoprim-resistant Enterobacteriaceae in urinary tract infection.
    Wong CK; Harding GK; Ronald AR; Hoban S
    Can Med Assoc J; 1975 Jun; 112(13 Spec No):54-8. PubMed ID: 1093652
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Distribution of integron-associated trimethoprim-sulfamethoxazole resistance determinants among Escherichia coli from humans and food-producing animals.
    Ho PL; Wong RC; Chow KH; Que TL
    Lett Appl Microbiol; 2009 Nov; 49(5):627-34. PubMed ID: 19780962
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Resistance of urinary tract isolates of Escherichia coli to trimethoprim, cotrimoxazole and ampicillin.
    Bailey RR; Peddie BA
    N Z Med J; 1988 Apr; 101(844):216-7. PubMed ID: 3283613
    [No Abstract]   [Full Text] [Related]  

  • 12. Resistance of urinary tract isolates of Escherichia coli to cotrimoxazole, sulphonamide, trimethoprim and ampicillin: an 11-year survey.
    Peddie BA; Bailey RR; Wells JE
    N Z Med J; 1987 Jun; 100(825):341-2. PubMed ID: 3330584
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Incidence of trimethoprim-sulfamethoxazole-resistant enterobacteriaceae among transplant recipients.
    Wells CL; Podzorski RP; Peterson PK; Ramsay NK; Simmons RL; Rhame FS
    J Infect Dis; 1984 Nov; 150(5):699-706. PubMed ID: 6387000
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Effect of the drug combination trimethoprim-sulfamethoxazole on the intestinal flora of man in short- and long-term administration].
    Knothe H
    Arzneimittelforschung; 1973 May; 23(5):704-8. PubMed ID: 4197002
    [No Abstract]   [Full Text] [Related]  

  • 15. Antibacterial activity in human urine of fosfomycin trometamol in an in vitro model of the urinary bladder.
    Dubini F; Riviera L
    Chemioterapia; 1988 Feb; 7(1):15-9. PubMed ID: 3259909
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Trimethoprim as a monosubstance and cotrimoxazole in infections of the efferent urinary tract].
    Ziak E; Sedlmayr P; Sterz F
    Wien Med Wochenschr; 1987 Mar; 137(5-6):123-6. PubMed ID: 3300045
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Microbiological basis for the use of fosfomycin trometamol as single-dose therapy for simple cystitis.
    Gismondo MR; Romeo MA; Lo Bue AM; Chisari G; Nicoletti G
    Chemioterapia; 1986 Aug; 5(4):278-82. PubMed ID: 3094965
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Cotrimoxazole resistance of Escherichia coli].
    Digranes A; Madsen ST
    Tidsskr Nor Laegeforen; 1979 Feb; 99(3):168, 156. PubMed ID: 369032
    [No Abstract]   [Full Text] [Related]  

  • 19. Role of thymidine for the activity of trimethoprim, sulfonamides and their combinations.
    Then RL
    Zentralbl Bakteriol A; 1980; 247(4):483-94. PubMed ID: 7006266
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effect of trimethoprim and trimethoprim-sulfamethoxazole on development of drug-resistant vaginal and fecal floras.
    Pancoast SJ; Hyams DM; Neu HC
    Antimicrob Agents Chemother; 1980 Feb; 17(2):263-8. PubMed ID: 7387147
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.